Yasuda M - Search Results

1

Changes in serum complements and their regulators in generalized myasthenia gravis.

Ozawa Y, Uzawa A, Yasuda M, Kojima Y, Oda F, Himuro K, Kawaguchi N, Kuwabara S. Ozawa Y, et al. Among authors: yasuda m. Eur J Neurol. 2021 Jan;28(1):314-322. doi: 10.1111/ene.14500. Epub 2020 Sep 27. Eur J Neurol. 2021. PMID: 32889770

2

Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.

Ozawa Y, Uzawa A, Kanai T, Oda F, Yasuda M, Kawaguchi N, Himuro K, Kuwabara S. Ozawa Y, et al. Among authors: yasuda m. J Neurol Sci. 2019 Jul 15;402:12-15. doi: 10.1016/j.jns.2019.05.003. Epub 2019 May 7. J Neurol Sci. 2019. PMID: 31100651

3

Frequency and features of myasthenia gravis developing after thymectomy.

Uzawa A, Kanai T, Oda F, Ozawa Y, Yasuda M, Kawaguchi N, Himuro K, Yoshino I, Kuwabara S. Uzawa A, et al. Among authors: yasuda m. Eur J Neurol. 2020 Jan;27(1):175-180. doi: 10.1111/ene.14052. Epub 2019 Aug 12. Eur J Neurol. 2020. PMID: 31347231

4

Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis.

Uzawa A, Ozawa Y, Yasuda M, Oda F, Kojima Y, Kawaguchi N, Kanai T, Himuro K, Kuwabara S. Uzawa A, et al. Among authors: yasuda m. J Neuroimmunol. 2020 Feb 15;339:577125. doi: 10.1016/j.jneuroim.2019.577125. Epub 2019 Dec 9. J Neuroimmunol. 2020. PMID: 31855720

5

Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study.

Uzawa A, Kojima Y, Ozawa Y, Yasuda M, Onishi Y, Akamine H, Kawaguchi N, Himuro K, Kuwabara S. Uzawa A, et al. Among authors: yasuda m. Clin Exp Immunol. 2020 Dec;202(3):321-324. doi: 10.1111/cei.13499. Epub 2020 Aug 10. Clin Exp Immunol. 2020. PMID: 32706905 Free PMC article.

6

Severe worsening of myasthenic symptoms after the eculizumab discontinuation.

Uzawa A, Ozawa Y, Yasuda M, Kuwabara S. Uzawa A, et al. Among authors: yasuda m. J Neuroimmunol. 2020 Dec 15;349:577424. doi: 10.1016/j.jneuroim.2020.577424. Epub 2020 Oct 9. J Neuroimmunol. 2020. PMID: 33068973

7

Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.

Uzawa A, Kuwabara S, Suzuki S, Imai T, Murai H, Ozawa Y, Yasuda M, Nagane Y, Utsugisawa K. Uzawa A, et al. Among authors: yasuda m. Clin Exp Immunol. 2021 Mar;203(3):366-374. doi: 10.1111/cei.13546. Epub 2020 Dec 3. Clin Exp Immunol. 2021. PMID: 33184844 Free PMC article. Review.

8

Dispersion of mean consecutive differences in single-fiber electromyography increases diagnostic sensitivity for myasthenia gravis.

Kojima Y, Shibuya K, Uzawa A, Kano H, Nakamura K, Yasuda M, Suzuki YI, Tsuneyama A, Suichi T, Ozawa Y, Misawa S, Noto YI, Mizuno T, Kuwabara S. Kojima Y, et al. Among authors: yasuda m. Muscle Nerve. 2021 Jun;63(6):885-889. doi: 10.1002/mus.27236. Epub 2021 Mar 31. Muscle Nerve. 2021. PMID: 33748989

9

Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome.

Kojima Y, Uzawa A, Ozawa Y, Yasuda M, Onishi Y, Akamine H, Kawaguchi N, Himuro K, Noto YI, Mizuno T, Kuwabara S. Kojima Y, et al. Among authors: yasuda m. J Neurol Neurosurg Psychiatry. 2021 Sep;92(9):963-968. doi: 10.1136/jnnp-2020-325511. Epub 2021 Mar 25. J Neurol Neurosurg Psychiatry. 2021. PMID: 33766920

10

Long-term outcomes and prognostic factors in generalized myasthenia gravis.

Ozawa Y, Uzawa A, Yasuda M, Kojima Y, Onishi Y, Oda F, Kanai T, Himuro K, Kawaguchi N, Kuwabara S. Ozawa Y, et al. Among authors: yasuda m. J Neurol. 2021 Oct;268(10):3781-3788. doi: 10.1007/s00415-021-10520-x. Epub 2021 Mar 27. J Neurol. 2021. PMID: 33774750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,567 results

Search Page

Filters